{"id":"W3043437003","doi":"10.1111/bjh.16945","title":"Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"University of Leeds; National Institute for Health and Care Research; Institute of Cancer Research; Cancer Research UK; Royal Marsden NHS Foundation Trust; National Cancer Research Institute; Celgene; University of Birmingham; Cancer Research Institute; Merck; Myeloma UK","keywords":"Medicine; Lenalidomide; Thalidomide; Multiple myeloma; Tolerability; Internal medicine; Discontinuation; Maintenance therapy; Cyclophosphamide; Dexamethasone; Oncology; Dosing; Surgery; Chemotherapy; Adverse effect","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003617481,0.0007099157,0.00182408,0.0002201498,0.0002406693,0.001343674,0.0005737167,0.0010419,0.001985382],"category_scores_gemma":[0.002518466,0.0002705013,0.002754332,0.0002895217,0.0005201026,0.0009420131,0.000487184,0.0027073,0.0003251902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007887133,"about_ca_system_score_gemma":0.0007676767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000520931,"about_ca_topic_score_gemma":0.001335399,"domain_scores_codex":[0.9989421,0.0005947836,0.0001019781,0.0001218449,0.00008539971,0.0001539717],"domain_scores_gemma":[0.9983329,0.0005426969,0.000498677,0.000110335,0.00007841372,0.0004370293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8917726,0.005920278,0.00514917,0.001052579,0.00260771,0.00006128536,0.0001672657,0.001201174,0.006797822,0.0001664595,0.00104941,0.08405426],"study_design_scores_gemma":[0.728472,0.2408786,0.02289049,0.0002661135,0.002366524,0.0001084535,0.00005641248,0.0009539984,0.001140294,0.0002826261,0.002542785,0.00004171128],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844151,0.0118438,0.0003917609,0.0007842454,0.0002501683,0.0008465502,0.0004236476,0.00003178498,0.001013063],"genre_scores_gemma":[0.9921769,0.003243271,0.001005394,0.001087898,0.0002222374,0.0007290267,0.0008103539,0.00001296505,0.000711908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003617481,"threshold_uncertainty_score":0.0191313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02275721751476278,"score_gpt":0.2808009717367239,"score_spread":0.2580437542219611,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}